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Nanotechnology has been used for medical applications in several forms, including dental practice with the development of
silver nanoparticles (Ag NPs) as a useful tool. The aim of this review was to identify the properties and appliances of Ag NPs
in dental practice. Silver compounds and NPs have already been used as dental restorative material, endodontic retrofill
cements, dental implants and caries inhibitory solution. Despite the effectiveness that Ag NPs has showed in dental practice,
Ag NPs remain a controversial area of research with respect to their toxicity in biological and ecological systems. Therefore
any application of Ag NPs in dentistry requires more studies. In order to avoided the toxicity of these materials Ag NPs can
be temporarily used in dentistry.
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INTRODUCTION
Nanotechnology, which concerns structures at the
nanometer scale (1–100 nm), is considered as a vital
current technology of the 21st century based on its
economic and scientific potential. In 2008, the public
expenditure of nanotechnology was 430 mmd com-
pared to 25 mmd in 19971,2. Nanoparticles (NPs) have
a greater surface-to-volume ratio (per unit mass) than
non-nanoscale particles of the same material, and
therefore are more reactive. Particles smaller than
50 nm are subject to the laws of quantum physics3.
In 2008 and 2009, silver production was 21 300 and
21 400 tons, respectively, according to United States
Geological Survey (USGS)4. Over the years, silver
compounds and NPs (Figure 1) have exhibited antibac-
terial activity resulting in the widespread use of silver
nanoparticles (Ag NPs) in bedding, washing machines,
water purification, toothpaste, shampoo and rinse,
nursing bottles, fabrics, deodorants, filters, kitchen
utensils, toys and humidifiers5. Furthermore, silver
compounds and NPs6 have been studied for dental
applications including dental restorative material7, end-
odontic retrofill cement8, dental implants9, and caries
inhibitory solution10. The aim of this brief review was to
identify the properties and appliances of Ag NPs in
dentistry practice.
ANTIMICROBIAL PROPERTIES
Most of the studies have indicated that silver interacts
with sulfhydryl groups of proteins and with DNA,
altering hydrogen bonding, respiratory processes, DNA
unwinding, cell-wall synthesis and cell division11,12. At
the macro level, these interactions effectively produce
bacterial death13.
It is recognized that Ag NPs have antimicrobial
activity against Gram-negative bacteria performing
‘pits’ in the cell wall of the bacteria. Clearly, a
membrane with such morphology exhibits a significant
increase in permeability, resulting in death of the cell.
Overall, silver mainly induces denaturation and oxidi-
zation for cell wall which lead to rupture of the
internal cell organelles, resulting in bacterial
death14,15. Although bacterial cell lysis could be one
of the reasons for the observed antibacterial property,
NPs also modulate the phosphotyrosine profile of
putative bacterial peptides, which could affect bacte-
rial signal transduction and inhibit the growth of the
organisms16.
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It is worth noting that the antibacterial activity of
nanosilver is dominated by silver ions (Ag+ ions) when
fine Ag NPs (less than about 10 nm in average
diameter) are employed that release high concentra-
tions of these ions. In contrast, when relatively larger
Ag NPs are used, the concentration of the released
Ag+ ions is lower17. Likewise, Ag NPs with average size
14 ± 6 nm and Ag+ ions such as AgNO3, inhibit the
growth of Escherichia coli 55 ± 8% and 100%,
respectively (Table 1 shows the antimicrobial effect of
Ag NPs).
Furthermore, silver particles are also used as alter-
native radiopacifier to get the necessary radiopacity to
calcium silicate cements (CSC) and assess the purity of
the radiopacifying agents18. These nanomaterials,
which can be prepared in a simple and cost-effective
manner, may be suitable for the formulation of new
types of bactericidal materials13.
CARIES INHIBITORY PROPERTIES
The most common worldwide oral diseases are dental
caries and periodontal diseases, 60–90%, according to
the World Health Organization (WHO)19. In Mexico,
some authors estimate that such diseases affect 90%
and 70% of the population, respectively20. In this
regard, the use of silver solution, specifically, silver
diamine fluoride (Ag [NH3] 2F) has been used as caries
inhibitor. In context, fluoride and silver interact syner-
gistically to form fluorapatite. The first step is the
formation of calcium fluoride (CaF2) and silver phos-
phate (Ag3PO4) in a basic environment, the second
reaction is the subsequent dissociation of calcium and
fluoride21.
Experimental composite adhesives (ECAs) showed
slower bacterial growth than those containing conven-
tional adhesives, suggesting that ECAs can help prevent
enamel demineralization around their surfaces without
compromising physical properties22.
RESTORATIVE MATERIALS
Whereas restorative materials with a silver polymer
compound have showed effective antimicrobial prop-
erties on implant components against Streptococcus
Table 1 Antimicrobial properties of Ag NPs
Gram-positive bacteria Streptococcus sanguis6
Bacillus subtilis35
Enterococcus faecalis35
Staphylococcus aureus36
Gram-negative bacteria Escherichia coli36
Salmonella typhimurium35
Shigella dysenteriae type 138
Citrobacter sp37
Pseudomona aeruginosa37
Pseudomona fluorescens38
Fungi Candida albicans39
Fusarium oxysporum37
Virus Arenavirus40
Human immunodeficiency virus-142
Murine norovirus41
Hepatitis B virus42
(a)
(b)
(c)
Figure 1. Scanning Electron Microscope views of Ag NPs. Illustra-
tion provided by Professor Rau´l Alberto Morales Luckie, Faculty of
Chemistry, UAEMex.
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sanguis6, silver has been incorporated into glass iono-
mer cements in order to improve the antibacterial
properties, including also, compressive, tensile strength
and creep resistance.
Biofilms are surface-adherent populations of micro-
organisms consisting of cells, water and extracellular
matrix material. Nanotechnology is a promising field of
science which can guide our understanding of the role
of interspecies interaction in the development of
biofilm. Streptococcus mutans with other species of
bacteria has been known to form dental biofilm. The
correlation between genetically modified bacteria Strep-
tococcus mutans and nanoscale morphology has been
assessed using atomic force microscopy (AFMi). Occa-
sionally, silver nanofibers have been attached to the
implant surfaces to reduce the need of using high doses
of antibiotics during the healing period, giving self-
cleaning against plaque biofilm9.
THERAPEUTICS
Nanostructures of different sizes, shapes and material
properties have many applications in biomedical imag-
ing, clinical diagnostics and therapeutics. In spite of
what has been achieved so far, a complete understand-
ing of how cells interact with nanostructures of well-
defined sizes, at the molecular level, remains poorly
understood.
Gold and Ag NPs coated with antibodies can regulate
the process of membrane receptor internalization.
The binding and activation of membrane receptors
and subsequent protein expression strongly depend on
nanoparticle size. Although all NPs within the
2–100 nm size range alter signaling processes essential
for basic cell functions (including cell death) 7, 40- and
50-nm NPs demonstrate the greatest effect. These
results show that NPs should no longer be viewed as
simple carriers for biomedical applications, but can also
play an active role in mediating biological effects. These
findings may assist in the design of nanoscale delivery
and therapeutic systems and provide insights into
nanotoxicity23.
ADVERSE EFFECTS
Metal ions are released from casting alloys and cause
damage to cell structures and local inflammation.
Ag(NH3)2F in contact to Human Gingival Fibroblast
(HGF) for only one hour induced irreversible necrosis cell
death, whereas longer duration of contact with AgCl was
necessary to induce this same effect. These data suggest
the importance of cautious application of Ag (NH3)2F
into the oral cavity24. Ag(NH3)2F shows much more
sensibility at dose-dependent ion against three normal
cells and three cancer line cells than AgCl (Figure 2a,b).
Nanotoxicity is the toxicity imposed by nanomateri-
als25. The toxic effects of Ag NPs are proportional to
the activity of free Ag+ ions released by the NPs26.
Although NPs have tremendous potential for a host of
applications, their adverse effects on living cells have
raised serious concerns for their use in the healthcare
and consumer sectors. For example, NPs may be taken
up directly into the brain by trans-synaptic transport
and Ag NPs can enter via the blood-brain barrier and
accumulate in different regions of the brain and this
may be beneficial for drug delivery, increasing a risk to
the patient. It has also been reported that nanoparticle
exposure can induce impairments to normal neuron-
microglia microenviroment and even aggravate the
process of brain pathology27.
In support of the damage notion, in vitro cell line
studies have shown decreased mitochondrial function
after exposure to Ag NPs in murine neuroblastoma
cells28, hepatic cells29, germline stem cells30, human
skin carcinoma31 and human epidermal keratinocytes
and fibroblasts32, while in vivo studies showed that
exposure to NPs could result in an inflammation,
oxidative stress, myocardial infarction and thrombosis33.
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Figure 2. Cytotoxicity of Ag(NH3)F2 and AgCl against six cell lines,
respectively. HPLF, human periodontal ligament ﬁbroblast cells;
HGF, human gingival ﬁbroblast cells; HPC, human pulp cells and
human oral squamous cells carcinoma obtained from different
patients (HSC-2, 3, 4) were incubated for 24 h with the indicated
concentrations of metal and then the relative viable cell number was
determined by MTT method. Each value represents the mean±S.D. of
triplicate assays. Reproducible results were obtained in further two
independent experiments.
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As above mentioned, NPs could alter the permeability
of blood brain barrier34.
Exposure to Ag NPs has been associated with tissue
damage especially in liver. In rats, it has been deter-
mined for Ag NPs a No Observable Adverse
Effect Level (NOAEL) of 30 mg ⁄kg and the Lowest
Observable Adverse Effect Level (LOAEL) of
125 mg ⁄kg35.
NPs could also damage DNA causing deletions,
mutations, single and double strand breakages, adduct
formation, and cross linking with proteins. Some
studies have confirmed DNA adducts and oxidation
and induced DNA fragmentation following exposure to
metal oxide NPs. In response to DNA insult, cells
attempt to repair damage DNA but repair failure may
lead to cell death (apoptosis) or cell transformation. In
the case of severe damage to DNA, cells may die by
either necrosis or apoptosis. In this regard, it has been
published previously that exposure to certain metal
oxide NPs induces apoptosis36.
Corrosion and discoloration of dental materials in
contact with Ag NPs may be a concern. On the other
hand, antibacterial property carries with it a potential
environmental risk once these NPs are discharged into
the environment. Of particular concern, Ag+ ions
from AgNO3 inhibit the algae’s photosynthesis around
18 times more than Ag NPs. However, over a long
period, the NPs are even more toxic than the ions
alone37. These environmental concerns have led to a
debate among advocacy groups and governments on
whether special regulation of nanotechnology is war-
ranted.
CONCLUSION
Despite the effectiveness that Ag NPs have showed in
dental practice, Ag NPs remain a controversial area of
research with respect to their toxicity in biological and
ecological systems38. Therefore any applications of Ag
NPs in dentistry requires more study. Initially, in order
to avoide the toxicity of these materials we think Ag
NPs can be used for temporary periods in the dental
field.
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